Device Trial Radar · NCT04154605
ClariFix Rhinitis RCT
Last checked: Nov 20, 2026Latest source record: Mar 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
133
Actual
Start
Nov 5, 2019
Primary completion
Mar 31, 2021
Study completion Jan 19, 2025
Sponsor
- Lead sponsor
- Stryker InstrumentsPublic (SYK)
- Sponsor type
- Industry
- Collaborators
- North American Science Associates Inc.
- First posted
- Nov 6, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, sham-controlled, single-blind study of cryotherapy as a treatment for chronic rhinitis.
Conditions
- Chronic Rhinitis
Interventions
ClariFix cryotherapyDevice
Bilateral freeze ablation of nasal tissue using the ClariFix device.
Sham ClariFix cryotherapyDevice
Bilateral sham ablation procedure using the ClariFix device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- rTNSS Responder RateTime frame: 90-days post treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ENT Associates of South Florida
Coral Springs, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.